New PET device could go to your head August 24, 2016 -- Researchers are developing quite the novel way to acquire PET brain scans. Rather than placing a patient in a conventional scanner, he or she would wear a helmet outfitted with PET detectors, according to an article published August 22 on Smithsonian.com.
Qubyx lands FDA clearance for monitor bundle August 23, 2016 -- Display calibration firm Qubyx Software Technologies has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a version of its PerfectLum calibration and quality assurance software that's bundled with Dell's UltraSharp UP3216Q monitor.
Lexmark expands product portfolio August 23, 2016 -- Printing firm and software developer Lexmark International has debuted several new software packages and services, including its Healthcare Content Management Viewer.
ViewRay to sell $14M in stock August 22, 2016 -- Image-guided radiotherapy developer ViewRay said it will sell $13.8 million in common stock in a financing effort led by current investors as it prepares to launch its MRIdian linear accelerator technology.
FDA OKs new MRI-conditional cochlear implant August 22, 2016 -- Cochlear Limited announced that the U.S. Food and Drug Administration (FDA) has cleared its Nucleus implants for MRI use up to 3 tesla when the implant's magnet has been removed.
CT separates bone mets from benign lesions August 22, 2016 -- Researchers in Boston say that CT attenuation measurements can be used to distinguish untreated osteoblastic metastases from enostoses, which are benign bone lesions, according to a study in the August American Journal of Roentgenology.
Later positive CT lung scans portend worse outcomes August 22, 2016 -- Individuals undergoing annual CT lung cancer screening fare worse when the results are positive in the second or third annual round, concludes a new study based on the National Lung Screening Trial. Conversely, patients who had a noncancerous positive result at the first screening lived longer.
Prostate cancer rates decline after USPSTF change August 19, 2016 -- Rates of early prostate cancer have continued to decline since the U.S. Preventive Services Task Force (USPSTF) recommended against routine prostate-specific antigen testing in all men in 2012, according to an article published online August 18 in JAMA Oncology.